Funded by Cancer Research UK, the study was conducted by scientists from the University of Cambridge and professor Christina Curtis from Stanford University.
The researchers analysed genetic change patterns in the tumours of approximately 2,000 breast cancer patients, tracking their progress over 20 years. Collected data was used to develop a statistical tool to help doctors predict the likelihood of recurrence after treatment. This new approach is expected to facilitate customised treatments in the future.
